FDA Needs to Step Up Its Game on Use of Device Registries: Report

Devices & Diagnostics Letter
Two years after the FDA proposed using device registries as tool to strengthen postmarket surveillance, some healthcare groups are saying the agency has not done enough to make that happen.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00